PROCEPT BioRobotics CorpPRCTEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 14.58% | 7.4M | — | 2024-02-09 |
| The Vanguard Group | 9.32% | 4.8M | flat | 2024-11-12 |
| BlackRock, Inc. | 6.60% | 3.4M | — | 2024-01-26 |
| T. Rowe Price Investment Management, Inc. | 2.00% | 1.0M | ▼ -5.30pp | 2024-11-14 |
| CPMG, INC. | 1.90% | 958.3K | ▼ -4.40pp | 2024-05-22 |
Insider Transactions
Net 90d: +$9.91M · buys $10.48M / sells $573.5KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-19 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (open market) | 3.0K | $25.82 | $78.3K |
| 2026-03-19 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (open market) | 2.3K | $26.15 | $61.0K |
| 2026-03-17 | Kevin Waters | EVP, CFO | Sell (open market) | 706 | $28.15 | $19.9K |
| 2026-03-17 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (open market) | 304 | $28.15 | $8.6K |
| 2026-03-10 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (open market) | 3.1K | $25.60 | $79.3K |
| 2026-03-10 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (open market) | 145 | $26.74 | $3.9K |
| 2026-03-09 | Desai Antal Rohit | Director | Buy (open market) | 43.6K | $24.08 | $1.05M |
| 2026-03-09 | Desai Antal Rohit | Director | Buy (open market) | 53.8K | $24.91 | $1.34M |
| 2026-03-09 | Desai Antal Rohit | Director | Buy (open market) | 1.3K | $25.42 | $33.0K |
| 2026-03-06 | Desai Antal Rohit | Director | Buy (open market) | 106.6K | $23.33 | $2.49M |
1–10 of 21
Page 1 / 3